CAMBRIDGE, Mass., May 14, 2018 /PRNewswire/ -- TriNetX™, the global health research network, today announced that it will present three posters on the use of real-world data from its federated electronic medical record (EMR)-based network as an established methodology for evaluating the safety and efficacy of treatments, during the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2018 annual meeting being held May 19-23 in Baltimore, Maryland.
"Our research shows that answers to very essential scientific questions can be found in real-world data, if you have the right data source, network and methods," said Manfred Stapff, MD, PhD, Chief Medical Officer at TriNetX. "The new and compelling fact is that these results could be obtained using real-world data in an extremely fast and efficient way, as compared to a costly and lengthy clinical trial. We look forward to having a dialogue at ISPOR with our peers in the medical community about these and other emerging methods."
Poster PCV4 - Comparison of Bleeding Events, Strokes, and Myocardial Infarctions on Warfarin or Dabigatran for Treatment of Atrial Fibrillation: Results of a Real-World Data Analysis
Poster PDB17 - A Real-World Data Analysis Evaluating the Time to Glycemic Control After Initiation of Basal Insulin in Type 2 Diabetic Patients
Poster PDB80 - Using Real-World Data to Establish an Optimal Treatment Target for HbA1c in Diabetes Type 2
TriNetX will also be exhibiting in booth #713 in the ISPOR expo hall.
About TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and contract research organizations (CROs) to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. Each member of our community shares in the consolidated value of our global, federated health research network that connects clinical researchers in real-time to the patient populations which they are attempting to study. For more information, visit https://www.trinetx.com or follow @TriNetX on Twitter.
Media Contact:
Jeff Stoecker
Racepoint Global
(518) 265-8370
trinetx@racepointglobal.com
SOURCE TriNetX